TNFRSF1A and liver disorder: In 1998, Douni and Kollias [39] reported that mice transgenic for the human TNFR2 developed a severe inflammatory syndrome, including inflammatory liver disease even in the absence of endogenous TNFR1, which supported the notion that TNFR2 primarily drives inflammation by increased NFκB activation.